Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,483
Closed -$120K 909
2023
Q1
$120K Buy
1,483
+86
+6% +$6.92K 0.01% 414
2022
Q4
$105K Buy
1,397
+119
+9% +$8.47K 0.01% 423
2022
Q3
$82K Buy
1,278
+533
+72% +$36.9K 0.01% 459
2022
Q2
$52K Buy
745
+30
+4% +$2.23K ﹤0.01% 557
2022
Q1
$55K Buy
715
+39
+6% +$2.81K ﹤0.01% 508
2021
Q4
$52K Sell
676
-39
-5% -$2.87K ﹤0.01% 503
2021
Q3
$53K Buy
715
+13
+2% +$975 0.01% 472
2021
Q2
$47K Sell
702
-590
-46% -$39.4K ﹤0.01% 487
2021
Q1
$96K Buy
1,292
+27
+2% +$2.05K 0.01% 346
2020
Q4
$92K Sell
1,265
-176
-12% -$12.4K 0.01% 326
2020
Q3
$96K Buy
1,441
+696
+93% +$44.1K 0.02% 271
2020
Q2
$42K Sell
745
-181
-20% -$8.88K 0.01% 381
2020
Q1
$33K Buy
926
+231
+33% +$11K 0.01% 322
2019
Q4
$36K Buy
+695
New +$34.6K 0.01% 269

Other funds holding HOLX

Ellevest Inc's HOLX Position: Q2 2023 in Review

Ellevest Inc sold out of Hologic (HOLX) in Q2 2023, closing a stake of 1,483 shares — an estimated $120K sold.

Ellevest Inc first reported a position in HOLX in Q4 2019 and held it in 14 quarters. The position peaked at $120K in Q1 2023. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Ellevest Inc reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 1,483 Hologic shares in Q2 2023, an estimated $120K.
  • Ellevest Inc first reported a position in Hologic in Q4 2019 and held it in 14 quarters.
  • Ellevest Inc's Hologic position peaked at $120K in Q1 2023.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.